Furthermore, TGFBI knockdown leads to SKOV-3 cells being resistant to paclitaxel, and TGFBI was considered a marker for paclitaxel-resistant ovarian cancer cell line [48]. The gene discussed is TGFBI; the disease is ovarian cancer.